Delphi consensus for the third-line treatment of metastatic colorectal cancer.
Pilar García AlfonsoRuth VeraEnrique ArandaElena ÉlezFernando RiveraPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
The experts agreed with most of the proposed items on 3L treatment of mCRC, prioritizing therapeutic options that increase survival and preserve QoL, while facilitating the possibility that patients can continue to be treated later.